Gefitinib: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
* Importance: It is the first selective inhibitor of Epidermal Growth Factor Receptors approved by the FDA | * Importance: It is the first selective inhibitor of Epidermal Growth Factor Receptors approved by the FDA | ||
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | * The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | ||
===Mechanism of Action=== | |||
===Pharmacokinetics=== | ===Pharmacokinetics=== | ||
{| class="wikitable" border="1" width="35%" style="text-align:center" | {| class="wikitable" border="1" width="35%" style="text-align:center" | ||